SpringerOpen will not pass on manuscripts to third parties outside springerOpen unless there is a suspicion of misconduct. For more information, please see our Policy on Misconduct. Manuscripts may be shared with other SpringerOpen editors unless the authors indicate at the time of submission that they do not wish their manuscript to be transmitted beyond the journal to which they submitted. For more information, see Peer Review Portability. In order to avoid ghostly authorship, corresponding authors may be required to disclose whether the manuscript has benefited from the use of editorial services which, if not recognised, could constitute an undisclosed conflict of interest. For example, the use of an editor from an organization that may have a legitimate interest in distorting the results, or the use of a technical writer at a level that would justify authorship. These situations can be approached differently by including a statement in the acknowledgements, describing the effort in the Methods section, or adding an author. In the case of experimental studies with client-owned animals, authors should also document the client`s or owner`s declaration of consent and adherence to a high standard (best practice) of veterinary care. Although a certain level of image processing is unavoidable for certain experiments, fields and techniques, the final image presented in the published article must in any case accurately represent the original data and comply with Community standards.

The guidelines for image processing presented below will contribute to the correct presentation of the data. Authors should also be careful to exercise caution when collecting data to avoid distorting the data collected. If a publisher or editorial board member is on the list of authors, they must indicate this in the “Competing Interests” section of the submitted manuscript. If the author is an author or has another competing interest in a particular manuscript, another editor or editorial board member is appointed to assume responsibility for overseeing the peer review. These submissions are subject to exactly the same review process as any other manuscript. For clinical trials that have not been prospectively registered, SpringerOpen encourages retrospective registration to ensure full publication of all results. For more information on retrospective registration, please contact the AllTrials campaign, the Audit Committee and the Ministry of Health. Financial interests: Author A received research support from Company A. Author B received speaker fees from companies Wall owns shares in Company X. Author C is an advisor to company Y. Note: There is a potential or actual conflict of interest when there are obligations and obligations.

SpringerOpen does not currently have a co-publication agreement with the Cochrane Library for its systematic reviews. SpringerOpen will therefore only consider publishing new systematic Cochrane reviews or updated versions of articles in the Cochrane Library if they provide substantial new information. In exceptional cases, Springer Nature reserves the right to remove an article, chapter, book or other content from Springer Nature`s online platforms. Such action may be taken if (i) Springer Nature has been advised that the Content is defamatory, infringes the intellectual property, privacy or other legal rights of a third party, or is otherwise unlawful; (ii) a court order has been or is likely to be issued requiring the removal of such content; (iii) the content, if implemented, would pose an immediate and serious risk to health. Withdrawal can be temporary or permanent. Bibliographic metadata (e.B titles and authors) is retained and accompanied by an explanation of why the content was removed. As part of SpringerNature, SpringerOpen is a member of CrossCheck`s plagiarism detection initiative and takes all instances of misconduct in publishing seriously. All suspected cases of secret submission of duplicate manuscripts will be dealt with as described in the COPE guidelines, and the publisher may contact the author`s institution (see Guidelines for Misconduct for more information).

SpringerOpen supports the ICMJE guidelines for overlapping publications. Since January 2012, the electronic publication of zoological names has been a valid form of publication if certain conditions are met. Manuscripts containing new names of taxa or other nomenclatural records must comply with the guidelines of the International Commission on Zoological Nomenclature. We need the new name of the taxon and the article in which it is published in order to be registered with zooBank. The unique identifier provided by ZooBank must be included in the published article. Authors can update ZooBank with the final citation after publication. More useful information from Frank-T. Krell is available here.

All research on humans (including human data and human material) and animals must have been conducted within an appropriate ethical framework (see our [Ethics] Policy for more information). If there is a suspicion that the research did not take place within an appropriate ethical framework, the publisher may reject a manuscript and inform third parties. B e.g. the author`s institution(s) and the ethics committee(s). Authors are invited to disclose interests that are directly or indirectly related to the work submitted for publication. Interests in the last 3 years following the start of the work (conducting the research and preparing the work for submission) must be reported. Interest outside the 3-year period must be disclosed if it can reasonably be perceived as an influence on the work submitted. Disclosure of interests provides a comprehensive and transparent process and helps readers form their own opinions about possible biases. This is not to say that a financial relationship with an organization that sponsored the research or the remuneration received for the consulting work is inappropriate. Financial interests: shares or shares of companies (including the interests of spouses and/or children) that may gain or lose financially through the publication of this manuscript; consulting fees or other forms of remuneration for organizations that may win or lose financially; Patents or patent applications whose value may be affected by the publication of this manuscript. Competing non-financial interests include (but are not limited to) competing political, personal, religious, ideological, academic and intellectual interests.

If, after reading these guidelines, you are not sure if you have a competing interest, please contact . In addition, they should exclude themselves from the processing of manuscripts if there is a competing interest. This may include – but is not limited to – having previously published with one or more of the authors and sharing the same institution as one or more of the authors. As part of SpringerNature, SpringerOpen is a member of the Committee on Publication Ethics (COPE) and supports the World Association of Medical Writers` (WAME) policy statement on geopolitical intrusion into editorial decisions. SpringerOpen also supports the recommendations of the International Committee of Medical Journal Editors (ICMJE) for the implementation, reporting, editing and publication of scientific articles in medical journals. Submitting a manuscript to a SpringerOpen journal implies that all authors have read and accepted its contents and that the manuscript complies with the journal`s guidelines. Springer Nature remains neutral with respect to claims of jurisdiction in published maps and institutional affiliations. Previous abstracts of up to 400 words and posters presented at academic conferences or published at scientific conferences do not preclude peer review of a complete manuscript, as the complete manuscript represents a formal advance over the citable scientific dataset. Published abstracts must be cited. Authors should be aware that many conference papers exceed the allowable word limit and represent a citable form.

For records containing clinical data, authors have an ethical and legal responsibility to respect the privacy rights of participants and protect their identity. Ideally, authors should obtain consent from participants to publish the dataset at the time of enrollment for the study. If this is not possible, authors must demonstrate that the publication of such data does not compromise anonymity or confidentiality or violate local data protection laws in order for the dataset to be considered for publication. Authors should check whether the dataset contains direct or indirect identifiers before submitting them (see here for more information) and consult their local ethics committee or other appropriate body if participants may not be completely anonymous. Authors must indicate in their manuscript at the time of submission whether informed consent has been obtained for the publication of patient data. If no informed consent has been obtained, authors must indicate the reason for this and which organization was consulted when the dataset was created. The above should be summarized in a statement and included in a section entitled “Statements” before the reference list. Other statements include funding, conflicts of interest/competing interests, ethical approval, consent, availability of data and/or code, and authors` contributions statements. The ICMJE uses the World Health Organization (WHO) definition of a clinical trial, which is “any research study that prospectively assigns human participants or groups of people to one or more health-related interventions to assess the impact on health outcomes.” This definition includes phase i to IV studies. The ICMJE defines health-related interventions as “any intervention used to modify a biomedical or health-related outcome” and health-related outcomes as “any biomedical or health-related measure received from patients or participants.” .